Instructions for Authors

Instructions for Authors

Manuscripts should be typed in 1.5 line spacing and 12 pt. Time New Roman with ample margins. Number all pages consecutively, and start each of the following sections on a new page:
 All contributions should be written in English. All articles must be submitted using word-processing software. All submissions must be typed in 1.5 line spacing and 12 pt. Time New Roman with ample margins. Required information for each of the manuscript sections is as follows: Title page The title page should carry.

 Cover Letter

  A cover letter should be written like a standard business letter. Address the editor formally by name, if known. Include your contact information, as well. This information is probably available through the journal’s online submission system, but it is proper to provide it in the cover letter, too. every cover letter should contain the following elements:
  1. An introduction stating the title of the manuscript and the journal to which you are submitting.
  2. The reason why your study is important and relevant to the journal’s readership or field.
  3. The question your research answers.
  4. Your major experimental results and overall findings.
  5. The most important conclusions that can be drawn from your research.
  6. A statement that the manuscript has not been published and is not under consideration for publication in any other journal
  7. A statement that all authors approved the manuscript and its submission to the journal.
  8. Any other details that will encourage the editor to send your manuscript for review.
  Write one or more sentences to address each of these points. You will revise and polish these sentences to complete your cover letter.

 Title Page 

  The title page must contain the following information:
  • Type of manuscript (e.g. Original article, Review article, Case Report, …)
  • Title: Title should be less than 12 words.
  • Authorship: Authorship credit should be in accordance with the standard proposed by International Committee of Medical Journal Editors, based on (1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors.
  • Running title: A short running title of less than 6 words (less than 50 characters) should be provided.
  • Affiliation/ Institution: Author names should be given first, then the complete name of institution, city, province and postcode.
  • Correspondence to: Only one corresponding address should be affiliation, the complete name of institution, city, postcode, province, country, telephone, fax, and email. All the letters in the email should be in lower case. Telephone and fax should consist of +, country number, district number and telephone or fax number, e.g., Tel/fax: + 98-11-33543614.
  • Up to five keywords or phrases suitable for use in an index (it is recommended to use MeSH terms).
  • Word count, excluding title page, abstract, references, figures and tables.
  • Registration number of clinical trials


Abstract should be structured with no more than 400 words for original articles and 250 words for brief articles and review articles. The specific requirements for abstracts are as follows:
Background: (no more than 40 words), AIM (no more than 25 words), only the purpose should be included.
Materials And Methods: (no more than 130 words)
Results: (no more than 170 words), you should present P values where appropriate and must provide relevant data to illustrate how they were obtained;
Conclusion: (no more than 35 words), the abstract should not be structured for other types of articles. Do not include references in abstract.
Keywords: Please list 3-7 key words, selected mainly from MeSH, which reflect the content of the study. Key word should be arranged alphabetically.


Main Text

For articles of these sections, original articles, brief articles and case reports, the main text should be structured into the following sections:
Introduction: State the purpose and summarize the rationale for the study or observation.
Materials and Methods: this section should only include information that was available at the time the study was planned or protocol written; all information obtained during the conduct of the study belongs to the results section. Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Because the relevance of such variables as age and sex to the object of research is not always clear, authors should explain their use when they are included in a study report; for example, authors should explain why only subjects of certain ages were included or why they excluded a gender from the study. The guiding principle should have clarity about how and why a study was done in a particular way. When authors use variables such as race or ethnicity, they should define how they measured the variables and justify their relevance. Technical information: Identify the methods, apparatus (give the manufacturer's name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration. Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement ( ).


Statistics: whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Define the statistical methods used to analyze the variables. Report losses to observation (such as drop outs from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyze them. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. For all P values include the exact value and not less than 0.05 or 0.001.


Result: Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Data should be presented in the main text or in Figures and Tables, but not in both. On the other hand, do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Extra or supplementary materials and technical detail can be placed in an appendix where it will be accessible but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. "Where scientifically appropriate, analyses of the data by variables such as age and sex should be included.


Include summary of key findings; Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence (is there a systematic review to refer to, if not, could one be reasonably done here and now?, what this study adds to the available evidence, effects on patient care and health policy, possible mechanisms); Controversies raised by this study; and Future research directions (for this particular research collaboration, underlying mechanisms, clinical research). Do not repeat in detail data or other material given in the Introduction or the Results section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly label them as such.

Figures /Illustrations

Figures should be numbered as 1, 2, 3, etc., and mentioned clearly in the main text. Provide a brief title for each figure on a separate page. Detailed legends should not be provided under the figures. This part should be added into the text where the figures are applicable. Figures should be either Photoshop or Illustrator files (in tiff, eps, jpeg formats) at high-resolution. It is our principle to publish high resolution figures for the printed and E-versions. If digital images are the only source of images, ensure that the image has minimum resolution of 300 dpi or 1800 x 1600 pixels in TIFF format. File names should identify the figure and panel. Avoid layering type directly over shaded or textured areas.


Three-line tables should be numbered 1, 2, 3, etc., and mentioned clearly in the main text. Provide a brief title for each table. Detailed legends should not be included under tables, but rather added into the text where applicable. The information should complement, but not duplicate the text. Use one horizontal line under the title, a second under column heads, and a third below the Table, above any footnotes. Vertical and italic lines should be omitted.

Ethical Considerations

Compliance with Ethical Guidelines

RMM is committed to apply ethics of publication, based on the COPE’s Code of Conduct and Best Practices. Also, in medical studies, RMM has engaged to apply ethics of research, based on Declaration of Helsinki: Statement of Ethical Principles for Medical Research. So, the research’s ethical considerations must be addressed in the Materials and Methods section and here briefly. For more information on the journal’s ethical Principles, please refer to following links:


All articles should have a funding statement under a separate heading entitled ‘Funding’ directly after your conclusions. Describe the sources of funding that have supported the work.

Authors' Contributions

The Authors’ Contributions section specifies the exact contributions of each author in a narrative form. This is a required section and all collaborators need to be listed in the Authors’ Contributions section.
Author Contributions: Conceptualization, Author names [A, B, C, or all authors]; Methodology, Author names [A, B, C, or all authors]; Investigation, Author names [A, B, C, or all authors]; Writing – Original Draft, Author names [A, B, C, or all authors]; Writing – Review & Editing, Author names [A, B, C, or all authors]; Funding Acquisition, Author names [A, B, C, or all authors]; Resources, Author names [A, B, C, or all authors]; Supervision, Author names [A, B, C, or all authors].

Conflicts of Interest

All authors of submitting articles to the journal must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. The Editor will discuss with the authors on an individual basis the method by which any conflicts of interest will be communicated to the readers.All authors must submit a statement of conflict of Interest to be published at the end of their article (conflict of Interest: non declared).


Acknowledgments Brief acknowledgments of persons who have made genuine contributions to the manuscript and who endorse the data and conclusions should be included. Authors are responsible for obtaining written permission to use any copyrighted text and/or illustrations.


This Journal accepts references according to a style based on Vancouver style (with some minor changes). Vancouver, a numbered style, follows rules established by the International Committee of Medical Journal Editors. Writing references as an ENDNOTE file will be considered as an advantage when submitting a manuscript. IN the text references: References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). If the same source is cited again later in the text, the same number is used once more. If multiple references are cited, use a hyphen to join an inclusive range of numbers thus: 2-5. Use commas without spaces to separate non-inclusive numbers in a multiple citation thus: 2-5, 7, and 10. Identify references in text, tables, and legends by Arabic numerals in superscript with after the punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Use complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. When the authors write the references, please ensure that the order in text is the same as in the references section, and also ensure the spelling accuracy of the first author’s name. Do not list the same citation twice. The commonly cited types of references are shown here, for other types of references such as electronic media; newspaper items, etc. please refer to ICMJE Guidelines ( or ).

Clinical Trial Registration

Neither the editors nor the publisher are responsible for the opinions expressed by contributors. We reserve the right to copy-edit accepted manuscripts and put them onto our website. Authors should follow the relevant guidelines for the care and use of laboratory animals of their institution or national animal welfare committee. For the sake of transparency in regard to the performance and reporting of clinical trials, we endorse the policy of the International Committee of Medical Journal Editors to refuse to publish papers on clinical trial results if the trial was not recorded in a publicly-accessible registry at its outset. The register now available is http://www.clinicaltrials.govsponsored by the United States National Library of Medicine, we encourage all potential contributors to register with it. However, in the event that other registers become available, such as, you will be duly notified. A letter of recommendation from each author’s organization should be provided with the contributed article to ensure the privacy and secrecy of research is protected. It is solely recommended that the authors should retain one copy of the text, tables, photographs and illustrations because rejected manuscripts will not be returned to the corresponding author(s) and the editors will not be responsible for loss or damage to photographs and illustrations sustained during mailing. Online submissions Manuscripts should be submitted through the Online Submission System at: For assistance, authors encountering problems with the Online Submission System may send an email describing the problem to,, or by telephone: +98-11-33543614. If you submit your manuscript online, do not make a postal contribution. Repeated online submission for the same manuscript is strictly prohibited.

Online Submission of the Manuscripts

All manuscripts must be submitted on-line through the website First time users will have to register at this site. Registered authors can keep track of their articles after logging into the site using their user name and password. Submission, processing or publication of articles in the RMM is free of charge. If you experience any problems, please contact our editorial office by e-mail at or

Online First publication

Most articles accepted for publication in RMM journal are published Online First within 3-4 weeks, often months ahead of publication in a printed journal issue. Online First articles are copy edited, typeset and approved by the author before being published as both typeset PDFs and searchable full text.

Report in Guidelines

The authors are encouraged to use the relevant research reporting guidelines for the study. This will ensure that you provide enough    information for editors, peer reviewers and readers to understand how the research was performed and to judge whether the findings are likely to be reliable.

  The key reporting guidelines are:

   · Randomized controlled trials (RCTs): CONSORT guidelines

   · Systematic reviews and meta-analyses: PRISMA guidelines  

   . Checklist of items that should be included in reports of cross-sectional studies

   . Checklist of items that should be included in reports of case-control studies

   . Checklist of items that should be included in reports of cohort studies

   . Checklist of items that should be included in reports of observational studies

   . Transparent reporting of systematic reviews and meta-analyses

   · Diagnostic accuracy studies: STARD guidelines 

   · Transparent Reporting of Evaluations with Non-randomised Designs: TREND guidlines

   · Standards for Reporting Prognostic Tumor Marker Studies: REMARK guidelines

Consolidated criteria for reporting qualitative research: COREQ Research checklists should be uploaded using the File Designation.


View: 17530 Time(s)   |   Print: 1700 Time(s)   |   Email: 85 Time(s)   |   0 Comment(s)


Designed & Developed by : Yektaweb